- Home
- NEUP vs USBC Comparison
NEUP vs USBC Comparison
Compare NEUP & USBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEUP
- USBC
- Stock Information
- Founded
- NEUP 1996
- USBC N/A
- Country
- NEUP United States
- USBC
- Employees
- NEUP N/A
- USBC N/A
- Industry
- NEUP
- USBC
- Sector
- NEUP
- USBC
- Exchange
- NEUP Nasdaq
- USBC Nasdaq
- Market Cap
- NEUP 12.7M
- USBC 14.5M
- IPO Year
- NEUP N/A
- USBC N/A
- Fundamental
- Price
- NEUP $9.40
- USBC $0.88
- Analyst Decision
- NEUP Strong Buy
- USBC
- Analyst Count
- NEUP 2
- USBC 0
- Target Price
- NEUP $28.00
- USBC N/A
- AVG Volume (30 Days)
- NEUP 86.8K
- USBC N/A
- Earning Date
- NEUP 11-15-2025
- USBC N/A
- Dividend Yield
- NEUP N/A
- USBC N/A
- EPS Growth
- NEUP N/A
- USBC N/A
- EPS
- NEUP 0.00
- USBC N/A
- Revenue
- NEUP $15,662,715.00
- USBC N/A
- Revenue This Year
- NEUP N/A
- USBC N/A
- Revenue Next Year
- NEUP N/A
- USBC N/A
- P/E Ratio
- NEUP $5,650.38
- USBC N/A
- Revenue Growth
- NEUP N/A
- USBC N/A
- 52 Week Low
- NEUP $2.90
- USBC N/A
- 52 Week High
- NEUP $126.00
- USBC N/A
- Technical
- Relative Strength Index (RSI)
- NEUP 43.51
- USBC N/A
- Support Level
- NEUP $11.42
- USBC N/A
- Resistance Level
- NEUP $15.14
- USBC N/A
- Average True Range (ATR)
- NEUP 1.62
- USBC 0.00
- MACD
- NEUP -0.38
- USBC 0.00
- Stochastic Oscillator
- NEUP 2.05
- USBC 0.00
About NEUP Neuphoria Therapeutics Inc. Common Stock
Neuphoria Therapeutics Inc is a clinical stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder.